Blumenthal Cancer Center
New Inquiries: 201-634-5339
Our Current Patients: Click for directory

Brain Cancer

Font ++ Click to Print


“A Phase II Randomized Trial Comparing the Efficacy of Heat Shock Protein-Peptide Complex-96 (HSPPC-96) (NSC#725085 Alliance IND # 15380) Vaccine Given With Bevacizumab Versus Bevacizumab Alone in the Treatment of Surgically Resectable Recurrent Glioblastoma Multiforme (GBM)”

Study Objective: The primary objective of the study is to determine whether there is an overall survival advantage of HSPPC-96 administered with bevacizumab, given concomitantly or at the point of progression, in comparison with bevacizumab alone in patients with surgically resectable recurrent glioblastoma multiforme.

  • Arm 1: Vaccine + bevacizumab
  • Arm 2: Vaccine, bevacizumab at progression
  • Arm 3: Bevacizumab

Principal Investigator: Anthony D'Ambrosio, M.D.

Click here for more information on A071101



"Randomized trial of veliparib or placebo in combination with adjuvant temozolomide in newly diagnosed GBM with MGMT promoter hypermethylation"

Study Objective: Test whether the experimental combination of ABT-888 (veliparib) combined with TMZ (temozolomide), compared to the control of placebo combined with TMZ, significantly extends overall survival in newly diagnosed glioblastoma multiforme (GBM) patients with tumor O-6-methylguanine-deoxyribonucleic acid (DNA) methyltransferase (MGMT) promoter hypermethylation.
  • Arm 1: Chemo + veliparib (investigational PARP inhibitor)
  • Arm 2: Chemo + placebo
Principal Investigator: Eli Kirshner, M.D.


The Valley Hospital Biorepository

For The Valley Hospital (TVH) patients undergoing surgical procedures, we offer the opportunity to participate in TVH Biorepository.  This protocol involves the freezing and storage of extra tissue not used for diagnosis, blood and other bodily fluids that may be used for future research designed to develop or contribute to generalized knowledge in cancer research. Available to all persons diagnosed with cancer, having surgery for excision, and is strongly encouraged.

Find a Doctor
View all physicians
Contact the Blumenthal Cancer Center

Have a question? Call 201-634-5339 or complete the form below. If you are experiencing a medical emergency, please call your doctor or emergency services provider.